| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |